AGXT and metabolic dysfunction-associated steatotic liver disease: The de novo pathway of ceramide synthesis has been extensively studied in respect to NAFLD, as palmitic acid (PAL), a 16:0 fatty acid, which is the most detrimental type of fat associated with the progression of NAFLD, is also the rate-limiting and key substrate for SPT.